MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

7.9 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • ALMKS had negative earnings in the past year.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • The Return On Assets of ALMKS (-0.94%) is worse than 62.12% of its industry peers.
  • ALMKS's Return On Equity of -4.48% is on the low side compared to the rest of the industry. ALMKS is outperformed by 62.12% of its industry peers.
  • With a decent Return On Invested Capital value of 7.00%, ALMKS is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • ALMKS had an Average Return On Invested Capital over the past 3 years of 2.93%. This is below the industry average of 7.74%.
  • The 3 year average ROIC (2.93%) for ALMKS is below the current ROIC(7.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROIC 7%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

1.3 Margins

  • In the last couple of years the Profit Margin of ALMKS has grown nicely.
  • ALMKS has a Operating Margin (1.87%) which is in line with its industry peers.
  • ALMKS's Operating Margin has declined in the last couple of years.
  • ALMKS's Gross Margin of 20.58% is on the low side compared to the rest of the industry. ALMKS is outperformed by 81.82% of its industry peers.
  • In the last couple of years the Gross Margin of ALMKS has declined.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.58%
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
  • Compared to 1 year ago, ALMKS has more shares outstanding
  • Compared to 5 years ago, ALMKS has more shares outstanding
  • ALMKS has a better debt/assets ratio than last year.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.79, we must say that ALMKS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.79, ALMKS is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • ALMKS has a debt to FCF ratio of 1.06. This is a very positive value and a sign of high solvency as it would only need 1.06 years to pay back of all of its debts.
  • ALMKS has a better Debt to FCF ratio (1.06) than 87.88% of its industry peers.
  • ALMKS has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.21, ALMKS is doing good in the industry, outperforming 71.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Altman-Z 1.79
ROIC/WACC1.03
WACC6.83%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • ALMKS has a Current Ratio of 0.84. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.84, ALMKS is doing worse than 60.61% of the companies in the same industry.
  • A Quick Ratio of 0.82 indicates that ALMKS may have some problems paying its short term obligations.
  • ALMKS has a Quick ratio (0.82) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 62.80% over the past year.
  • The Earnings Per Share has been growing by 64.14% on average over the past years. This is a very strong growth
  • The Revenue has grown by 16.02% in the past year. This is quite good.
  • The Revenue has been growing by 43.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%

3.2 Future

  • ALMKS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -63.53% yearly.
  • ALMKS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.23% yearly.
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMKS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 70.41 indicates a quite expensive valuation of ALMKS.
  • Based on the Price/Forward Earnings ratio, ALMKS is valued a bit more expensive than 60.61% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.16. ALMKS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 70.41
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALMKS is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, ALMKS is valued cheaper than 98.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.87
EV/EBITDA 5.78
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ALMKS's earnings are expected to decrease with -63.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.53%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • ALMKS has a Yearly Dividend Yield of 2.32%.
  • Compared to an average industry Dividend Yield of 3.40, ALMKS has a dividend in line with its industry peers.
  • ALMKS's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALMKS.PA Yearly Dividends per shareALMKS.PA Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y-63.53%
EPS Next 3YN/A
ALMKS.PA Yearly Income VS Free CF VS DividendALMKS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (4/14/2026, 7:00:00 PM)

7.9

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners4.21%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap71.81M
Revenue(TTM)273.54M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-70.27%
EPS NY rev (3m)-73.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.41
P/S 0.26
P/FCF 1.87
P/OCF 1.86
P/B 1.87
P/tB N/A
EV/EBITDA 5.78
EPS(TTM)-0.19
EYN/A
EPS(NY)0.11
Fwd EY1.42%
FCF(TTM)4.22
FCFY53.44%
OCF(TTM)4.24
OCFY53.68%
SpS30.09
BVpS4.22
TBVpS-2.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROCE 9.53%
ROIC 7%
ROICexc 19.52%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.58%
FCFM 14.03%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ROICexc(3y)5.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
F-Score6
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Debt/EBITDA 0.63
Cap/Depr 2.28%
Cap/Sales 0.06%
Interest Coverage 1.19
Cash Conversion 304.51%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 1.79
F-Score6
WACC6.83%
ROIC/WACC1.03
Cap/Depr(3y)8.61%
Cap/Depr(5y)162.22%
Cap/Sales(3y)0.2%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y279.09%
EBIT growth 3YN/A
EBIT growth 5Y-40.98%
EBIT Next Year83.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76352.4%
FCF growth 3Y58.75%
FCF growth 5YN/A
OCF growth 1Y11729.2%
OCF growth 3Y52.22%
OCF growth 5Y61.77%

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 2 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


How profitable is MAKING SCIENCE GROUP SA (ALMKS.PA) stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 3 / 10.